Tirzepatide 10mg | Dual GIP/GLP-1 Agonist | 99% Purity | Third-Party Tested

Product Overview

Tirzepatide is a synthetic dual incretin receptor agonist peptide consisting of 39 amino acids. This research-grade peptide functions as both a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide has been extensively studied in laboratory settings for its unique dual receptor binding mechanism and cellular signaling properties. Tirzepatide is frequently researched alongside Semaglutide in comparative incretin receptor agonist studies.

Our Tirzepatide research peptide is manufactured to the highest standards, with third-party verified purity exceeding 99%. Each vial contains 10mg of lyophilized (freeze-dried) peptide powder, accompanied by a Certificate of Analysis (COA) from an independent laboratory.

Research Applications

Tirzepatide has been the subject of numerous peer-reviewed studies examining its role as a dual incretin receptor agonist. Research has focused on its molecular binding affinity to both GIP and GLP-1 receptors, comparative receptor selectivity analysis, and intracellular signaling cascade mechanisms. Published studies have investigated Tirzepatide’s molecular pathways in cell culture models and laboratory environments.

Research applications include:

• Dual receptor binding studies: Examination of simultaneous GIP and GLP-1 receptor interactions and binding kinetics in vitro
• Incretin signaling pathway research: Investigation of cAMP production, insulin secretion pathways, and downstream molecular cascades
• Comparative incretin studies: Often studied alongside Semaglutide to examine differential receptor agonism mechanisms and selectivity profiles
• Peptide structure-activity analysis: Study of molecular modifications, receptor binding domains, and structure-function relationships

Important: This product is intended for laboratory research use only. It is not approved for human consumption, clinical use, or any diagnostic or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease.

Product Specifications

• Peptide Name: Tirzepatide
• Classification: Dual GIP/GLP-1 Receptor Agonist
• Amino Acid Length: 39 amino acids
• Molecular Formula: C225H348N48O68
• Molecular Weight: 4813.5 g/mol
• Dosage per Vial: 10mg
• Form: Lyophilized (freeze-dried) white powder
• Purity: >99% (verified by third-party HPLC analysis)
• Storage: Store lyophilized peptide at -20°C. After reconstitution, store at 2-8°C and use within 30 days for optimal stability.
• Packaging: Sterile sealed vial with tamper-evident cap

Quality & Purity Guarantee

Every batch of our Tirzepatide peptide undergoes rigorous third-party testing to ensure maximum purity and quality:

• HPLC Analysis: High-Performance Liquid Chromatography confirms peptide purity >99%
• Mass Spectrometry: Verifies molecular weight and sequence accuracy
• Certificate of Analysis: Each order includes a COA from an independent, accredited laboratory
• Sterility Testing: Ensures product is free from microbial contamination
• Endotoxin Testing: Confirms safe levels for research applications

We are committed to providing researchers with the highest quality peptides for advancing scientific knowledge.

Frequently Asked Questions

What is Tirzepatide?

Tirzepatide is a synthetic dual incretin receptor agonist consisting of 39 amino acids that functions as both a GIP and GLP-1 receptor agonist. It has been extensively studied in preclinical research settings for its unique dual receptor binding mechanism and comparative molecular properties relative to single-receptor agonists.

What is Tirzepatide used for in research?

Tirzepatide is used in laboratory research to study dual incretin receptor mechanisms, comparative receptor selectivity, and molecular signaling pathways. Research applications include receptor binding assays, cellular signaling cascade analysis, and comparative studies with single-receptor agonists like Semaglutide. This product is for research purposes only and is not intended for human consumption.

How should Tirzepatide be stored?

Store lyophilized Tirzepatide at -20°C (freezer) for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C (refrigerator) and use within 30 days for optimal stability. Avoid repeated freeze-thaw cycles.

Does each vial come with a Certificate of Analysis?

Yes, every batch of our Tirzepatide peptide is tested by an independent, third-party laboratory. Each order includes access to the Certificate of Analysis (COA) verifying purity, molecular weight, and quality specifications.

How does Tirzepatide compare to Semaglutide in research?

Tirzepatide and Semaglutide are frequently compared in research settings. While Semaglutide is a selective GLP-1 receptor agonist, Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, allowing researchers to examine differential receptor binding mechanisms, signaling pathway activation patterns, and comparative molecular effects. All research should be conducted in controlled laboratory environments by qualified personnel.

What is the molecular structure of Tirzepatide?

Tirzepatide is a synthetic peptide consisting of 39 amino acids with specific structural modifications enabling dual receptor agonism. Its molecular formula is C225H348N48O68 with a molecular weight of 4813.5 g/mol. The peptide structure includes modifications that confer binding affinity to both GIP and GLP-1 receptors.

Research Disclaimer

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.

This product is sold exclusively for research and laboratory purposes. Tirzepatide is not approved by the FDA for human use, clinical applications, or any diagnostic or therapeutic purposes when sold as a research peptide. This product is not intended to diagnose, treat, cure, or prevent any disease. Researchers should follow all applicable laws, regulations, and institutional guidelines when handling this material.

By purchasing this product, you acknowledge that you are a qualified researcher or acting on behalf of a research institution, and that this peptide will be used solely for in-vitro or laboratory research purposes.

Related Research Peptides

Researchers studying Tirzepatide may also be interested in these complementary peptides:

• Semaglutide (GLP-1 Receptor Agonist) – Single-receptor agonist frequently studied in comparative incretin research with Tirzepatide
• BPC-157 (Body Protection Compound-157) – Tissue research peptide with complementary molecular mechanisms
• CJC-1295 – Growth hormone releasing peptide for GH pathway research
• AOD-9604 – Fragment peptide for metabolic research applications